@article{129d4b7bd0604e879d81f972e4debf81,
title = "Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions",
keywords = "cerebral aneurysm, cortical spreading depolarization, delayed cerebral ischemia, early brain injury, endothelial cells, inflammation, smooth muscle cell, subarachnoid hemorrhage, vasospasm, DELAYED CEREBRAL-ISCHEMIA, RANDOMIZED CONTROLLED-TRIAL, EARLY BRAIN-INJURY, INTRAVENOUS MAGNESIUM-SULFATE, PLACEBO-CONTROLLED TRIAL, RUPTURED INTRACRANIAL ANEURYSMS, TISSUE-PLASMINOGEN ACTIVATOR, VEHICLE-CONTROLLED TRIAL, DOSE TIRILAZAD MESYLATE, SMOOTH-MUSCLE-CELLS, 3126 Surgery, anesthesiology, intensive care, radiology, 3112 Neurosciences, 317 Pharmacy",
author = "Serrone, {Joseph C.} and Hidetsugu Maekawa and Mardjono Tjahjadi and Juha Hernesniemi",
year = "2015",
month = apr,
doi = "10.1586/14737175.2015.1018892",
language = "English",
volume = "15",
pages = "367--380",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Taylor & Francis",
number = "4",
}